2024
Clinical characteristics associated with problematic pornography use among individuals seeking treatment for opioid use disorder.
Stefanovics E, Kraus S, Madden L, Farnum S, Cannata E, Potenza M, Barry D. Clinical characteristics associated with problematic pornography use among individuals seeking treatment for opioid use disorder. Journal Of Behavioral Addictions 2024 PMID: 39298267, DOI: 10.1556/2006.2024.00037.Peer-Reviewed Original ResearchBrief Pornography ScreenOpioid use disorderPornography useOpioid use disorder treatmentUse disorderMeasures of substance useMeasures of impulsivityProblematic pornography useMinority of individualsNegative urgencyPositive urgencyPsychotic symptomsSelf-reported dataBehavioral addictionsGambling disorderPsychiatric disordersPsychiatric symptomsSensation-seekingEmotional labilitySelf-harmSubstance useDisordersOpioidIndividualsSymptomsCurrent Understanding of Compulsive Sexual Behavior Disorder and Co-occurring Conditions: What Clinicians Should Know about Pharmacological Options
Mestre-Bach G, Potenza M. Current Understanding of Compulsive Sexual Behavior Disorder and Co-occurring Conditions: What Clinicians Should Know about Pharmacological Options. CNS Drugs 2024, 38: 255-265. PMID: 38485889, DOI: 10.1007/s40263-024-01075-2.Peer-Reviewed Original ResearchConceptsCompulsive sexual behavior disorderSexual behavior disorderReuptake inhibitorsBehavioral disordersPornography usePharmacological treatmentCo-occurring disordersEmpirical supportSerotonin reuptake inhibitorsCo-occurring conditionsMood stabilizersPsychiatric disordersPsychological therapiesTricyclic antidepressantsGeneralizability of resultsOpioid antagonistSerotonin antagonistsDisordersSerotoninPharmacological optionsPharmacological approachesAntagonistPharmacological therapyNarrative reviewNefazodoneDiagnosis and Treatment of Gambling Addiction
Mestre-Bach G, Potenza M. Diagnosis and Treatment of Gambling Addiction. 2024 DOI: 10.1093/acrefore/9780190264086.013.135.Peer-Reviewed Original ResearchTreatment of gambling addictionPsychiatric disordersPsychiatric concernsGambling addictionPsychological factorsYoung adultsDiagnostic criteriaComplicate treatmentSocietal harmNeurobiologyAddictionNeurochemistryNeuroimagingAdolescentsShameDisordersIncreased considerationLimited screeningTreatmentAdultsAmbivalenceStigma
2023
The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder
Castagna P, Farahdel E, Potenza M, Crowley M. The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder. Expert Opinion On Pharmacotherapy 2023, 24: 835-847. PMID: 37074259, PMCID: PMC10197951, DOI: 10.1080/14656566.2023.2199921.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsSelective serotonin reuptake inhibitorsSelective norepinephrine reuptake inhibitorGeneralized anxiety disorderAnxiety disordersReuptake inhibitorsPediatric generalized anxiety disorderBetter long-term outcomesSecond-line treatmentNorepinephrine reuptake inhibitorsSerotonin reuptake inhibitorsFirst-line interventionLong-term outcomesCombination of psychotherapyPrevalent psychiatric disordersEvidence-based statePediatric anxiety disordersArt pharmacotherapyModerate effect sizeFunctional outcomeEarly recognitionMood disordersElevated riskPsychiatric disordersBetter outcomesElectronic databasesUse of experimental medicine approaches for the development of novel psychiatric treatments based on orexin receptor modulation
Beckenstrom A, Coloma P, Dawson G, Finlayson A, Malik A, Post A, Steiner M, Potenza M. Use of experimental medicine approaches for the development of novel psychiatric treatments based on orexin receptor modulation. Neuroscience & Biobehavioral Reviews 2023, 147: 105107. PMID: 36828161, PMCID: PMC10165155, DOI: 10.1016/j.neubiorev.2023.105107.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsExperimental medicine approachPerformance outcome measuresPsychiatric disordersMedicine approachReal-world clinical practiceOrexin neuropeptide systemMarkers of efficacyPatient advocacy groupsOrexin modulationReceptor modulationSymptom evaluationReceptor modulatorsClinical studiesMood disordersPreclinical studiesNeuropeptide systemsPsychiatric treatmentAnimal modelsPathological mechanismsClinical practiceClinical researchClinical useBrain functionTranslational researchPotential target
2022
The World Federation of Societies of Biological Psychiatry guidelines on the assessment and pharmacological treatment of compulsive sexual behaviour disorder
Turner D, Briken P, Grubbs J, Malandain L, Mestre-Bach G, Potenza M, Thibaut F. The World Federation of Societies of Biological Psychiatry guidelines on the assessment and pharmacological treatment of compulsive sexual behaviour disorder. Dialogues In Clinical Neuroscience 2022, 24: 10-69. PMID: 37522807, PMCID: PMC10408697, DOI: 10.1080/19585969.2022.2134739.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPharmacological treatmentCompulsive sexual behavior disorderBehavior disorderBiological Psychiatry (WFSBP) GuidelinesRelevant pharmacological treatmentFirst-choice treatmentTreatment of adultsType of medicationTreatment of patientsSexual behavior disorderParaphilic disordersStrength of evidenceChemsex behavioursHormonal agentsTreatment recommendationsCurrent guidelinesPsychiatric disordersPharmacological agentsClinical practiceExtensive literature searchLiterature searchPatientsGoogle ScholarDisordersWorld Federation
2019
Problem-Gambling Severity, Suicidality, and DSM-IV Axis I Psychiatric Disorders
Ronzitti S, Kraus S, Hoff R, Clerici M, Potenza M. Problem-Gambling Severity, Suicidality, and DSM-IV Axis I Psychiatric Disorders. International Journal Of Mental Health And Addiction 2019, 19: 462-477. DOI: 10.1007/s11469-019-00080-7.Peer-Reviewed Original ResearchAxis I psychiatric disordersDSM-IV Axis I psychiatric disordersPsychiatric disordersAxis IPanic disorderSuicidality levelsLogistic regression analysisNational Epidemiologic SurveyRelated Conditions studyEpidemiologic SurveyLow-risk gamblingMood symptomatologySuicidal ideationSociodemographic characteristicsSuicide attemptsBivariate analysisSeveritySuicidal tendenciesSuicidalityDisordersProblem-gambling severityRegression analysisWave 1Ideation
2016
Gender-related differences in the associations between sexual impulsivity, psychiatric disorders and trauma
Erez G, Pilver C, Potenza M. Gender-related differences in the associations between sexual impulsivity, psychiatric disorders and trauma. European Psychiatry 2016, 33: s42. DOI: 10.1016/j.eurpsy.2016.01.893.Peer-Reviewed Original ResearchGender-related differencesPsychiatric disordersSubstantial public health costsAxis II psychiatric disordersAlcohol abuse/dependenceAssociated Disabilities InterviewPersonality disorderSexual impulsivityDiagnosis of moodDSM-IV versionAbuse/dependenceNational Epidemiologic SurveyAlcohol use disorderSignificant gender-related differencesPublic health costsUnintended pregnancySecondary data analysisUse disordersEpidemiologic SurveyDSM-IVMost personality disordersRelated conditionsTraumaDisordersWomen
2011
Overview of the Impulse Control Disorders Not Elsewhere Classified and Limitations of Knowledge
Grant J, Potenza M. Overview of the Impulse Control Disorders Not Elsewhere Classified and Limitations of Knowledge. 2011, 4-10. DOI: 10.1093/oxfordhb/9780195389715.013.0012.ChaptersImpulsivity and Co-occurring Psychiatric Disorders
Hirschtritt M, Potenza M, Mayes L. Impulsivity and Co-occurring Psychiatric Disorders. 2011, 81-93. DOI: 10.1093/oxfordhb/9780195389715.013.0033.ChaptersDual diagnosisPsychiatric disordersCo-occurring psychiatric disordersSubstance abuseCo-occurring phenotypesDual diagnosis disordersHomogeneous diagnostic groupsPresence of impulsivityAttention-deficit/hyperactivity disorderBorderline personality disorderTreatment recommendationsBipolar disorderDiagnostic groupsClinical plansHyperactivity disorderPersonality disorderDisordersDiagnosisHigh impulsivityBehavioral findingsImpulsivityBiochemical differencesAbuseComorbiditiesGroup
2010
The Biology and Treatment of Pathological Gambling
Balodis I, Potenza M. The Biology and Treatment of Pathological Gambling. 2010, 617-631. DOI: 10.1007/978-1-4419-0338-9_29.ChaptersPathological gamblingIntelligence quotient (IQ) testingCognitive distortionsNeuropsychological studiesImpulse control disordersCo-occurring psychiatric disordersPathological gamblersIntellectual differencesMood regulationSuperstitious beliefsGamblingBrain areasSubstance dependenceGambling lossesControl disordersPsychiatric disordersMost adultsRisk/Pharmacological treatmentDisordersGamblersNeurotransmitter norepinephrineTreatment efficacyNeurobiologyAddiction
2007
Impulse Control Disorders and Co-Occurring Disorders: Dual Diagnosis Considerations
Potenza M. Impulse Control Disorders and Co-Occurring Disorders: Dual Diagnosis Considerations. Journal Of Dual Diagnosis 2007, 3: 47-57. DOI: 10.1300/j374v03n02_06.Peer-Reviewed Original Research